Figure 3.
Figure 3. Nonmutational mechanisms inactivating wtp53 in AML. The asterisk in the “Deregulated posttranslational modifications” column denotes deacetylated p53. In certain AML entities, wtp53 inactivation results from ≥1 underlying mechanism. APL, acute promyelocytic leukemia; dec., decreased; incr., increased; NK, normal karyotype.

Nonmutational mechanisms inactivating wtp53 in AML. The asterisk in the “Deregulated posttranslational modifications” column denotes deacetylated p53. In certain AML entities, wtp53 inactivation results from ≥1 underlying mechanism. APL, acute promyelocytic leukemia; dec., decreased; incr., increased; NK, normal karyotype.

Close Modal

or Create an Account

Close Modal
Close Modal